These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 29022279

  • 1. The role of α1- and α2-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats.
    Rivera-Mancilla E, Avilés-Rosas VH, Manrique-Maldonado G, Altamirano-Espinoza AH, Villanueva-Castillo B, MaassenVanDenBrink A, Villalón CM.
    J Headache Pain; 2017 Oct 11; 18(1):104. PubMed ID: 29022279
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats.
    Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Centurión D.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):262-9. PubMed ID: 23707349
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes.
    Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Centurión D.
    Eur J Pharmacol; 2013 Oct 15; 718(1-3):245-52. PubMed ID: 24028939
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological analysis of the mechanisms involved in the tachycardic and vasopressor responses to the antimigraine agent, isometheptene, in pithed rats.
    Valdivia LF, Centurión D, Perusquía M, Arulmani U, Saxena PR, Villalón CM.
    Life Sci; 2004 May 14; 74(26):3223-34. PubMed ID: 15094323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological evidence that 5-HT1A/1B/1D, α2-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats.
    Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Gutiérrez-Lara EJ, Centurión D.
    Eur J Pharmacol; 2014 Oct 05; 740():512-21. PubMed ID: 24975101
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological identification of the α₂-adrenoceptor subtypes mediating the vasopressor responses to B-HT 933 in pithed rats.
    Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Manrique-Maldonado G, Villalón CM, Centurión D.
    Eur J Pharmacol; 2012 Sep 15; 691(1-3):118-24. PubMed ID: 22713550
    [Abstract] [Full Text] [Related]

  • 9. Alpha1-adrenoceptor subtypes mediating vasoconstriction in the carotid circulation of anaesthetized pigs: possible avenues for antimigraine drug development.
    Willems EW, Heiligers JP, De Vries P, Kapoor K, Tom B, Villalón CM, Saxena PR.
    Cephalalgia; 2001 Mar 15; 21(2):110-9. PubMed ID: 11422093
    [Abstract] [Full Text] [Related]

  • 10. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM, De Vries P, Rabelo G, Centurión D, Sánchez-López A, Saxena P.
    Br J Pharmacol; 1999 Feb 15; 126(3):585-94. PubMed ID: 10188968
    [Abstract] [Full Text] [Related]

  • 11. 5-HT1B receptors, alpha2A/2C- and, to a lesser extent, alpha1-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomised dogs.
    Valdivia LF, Centurión D, Arulmani U, Saxena PR, Villalón CM.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul 15; 370(1):46-53. PubMed ID: 15224175
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    Lozano-Cuenca J, Muñoz-Islas E, González-Hernández A, Centurión D, Cobos-Puc LE, Sánchez-López A, Pertz HH, Villalón CM.
    Eur J Pharmacol; 2009 Jun 10; 612(1-3):80-6. PubMed ID: 19356724
    [Abstract] [Full Text] [Related]

  • 13. Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein.
    Errasti AE, Velo MP, Torres RM, Sardi SP, Rothlin RP.
    Br J Pharmacol; 1999 Jan 10; 126(2):437-42. PubMed ID: 10077236
    [Abstract] [Full Text] [Related]

  • 14. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
    McDaid J, Docherty JR.
    Br J Pharmacol; 2001 Jun 10; 133(3):429-37. PubMed ID: 11375260
    [Abstract] [Full Text] [Related]

  • 15. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D, Mehotra S, Sánchez-López A, Gupta S, MaassenVanDenBrink A, Villalón CM.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):234-42. PubMed ID: 16545797
    [Abstract] [Full Text] [Related]

  • 16. Neurogenic double-peaked vasoconstriction of human gastroepiploic artery is mediated by both alpha1- and alpha2-adrenoceptors.
    Fukui D, Yang XP, Chiba S.
    Br J Pharmacol; 2005 Mar 27; 144(6):737-42. PubMed ID: 15685216
    [Abstract] [Full Text] [Related]

  • 17. Fentanyl attenuates alpha1B-adrenoceptor-mediated pulmonary artery contraction.
    Sohn JT, Ding X, McCune DF, Perez DM, Murray PA.
    Anesthesiology; 2005 Aug 27; 103(2):327-34. PubMed ID: 16052115
    [Abstract] [Full Text] [Related]

  • 18. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat.
    Docherty JR.
    Eur J Pharmacol; 2012 Mar 15; 679(1-3):90-4. PubMed ID: 22290390
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs.
    Willems EW, Valdivia LF, Saxena PR, Villalón CM.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul 15; 364(1):27-32. PubMed ID: 11485035
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.